Nutrition 21 litigation
This article was originally published in The Tan Sheet
Executive Summary
Purchase N.Y.-based firm files motion for partial summary judgement against InterHealth Nutraceuticals to halt six alleged instances of false advertising for ChromeMate chromium nicotinate dietary supplement. In complaint, filed in Manhattan federal court Sept. 24, Nutrition 21 asserts InterHealth ads have misled consumers about the safety of ChromeMate respective to Nutrition 21's Chromax chromium picolinate dietary supplement. Company is seeking damages including judgement that ads are false, corrective advertising and monetary damages, according to a spokesperson...
You may also be interested in...
Robust Trial Transparency Strategy Boosts Patient Engagement
Most clinical trial sponsors view data disclosure as a mandate, maintaining regulatory compliance as a legal requirement. Study sponsors that realize the potential to repurpose this data, using a patient-first approach, turn transparency into a strategic advantage for engagement and recruitment efforts.
Medtronic’s Perfusion System Recall Is Fifth Class I In 2 Months
The Bio-Console 560 extracorporeal blood pumping console is being recalled over reports it could lose power during bypass surgery, which could lead to organ or neural dysfunction, blood clots, or even death.
US House Co-signs Banking For Hemp Industry
House passes “SAFE Banking” Act sponsored by Rep. Ed Perlmutter to allow cannabis- and hemp-related businesses in states with some form of legalized marijuana to access financial services by creating protections for those institutions. Sen. Jeff Merkley introduced the same legislation in March.